Characterization and Selection of Antibodies for Covid-19 Diagnostics Using SPR
By January 2021, just over a year after the virus was first identified, there were over 100 million cases of COVID-19 reported worldwide and several viral variants in circulation. The unprecedented nature of the pandemic has magnified the need for accelerated scientific discoveries as researchers strive to bring novel therapeutics, vaccines and diagnostic solutions to market.
What You Will Learn:
Versatility & Flexibility: How the robustness and sensitivity of SPR makes it ideal for a wide range of biomolecular applications
Comprehensive workflows: The benefits of SPR-based characterization studies for accelerating lead time on novel COVID-19 solutions
Maximizing performance: How to develop a highly selective and specific antibody pair with SPR to optimize COVID-19 antigen detection
Looking ahead: The next generation of SPR platforms advancing label-free detection to address the unmet needs of infectious disease research
Please complete the form below.
"*" indicates required fields
Labroots DART webinar popup
Introduction to Digital SPR and its use in assessing the
binding kinetics of DART (Drugs Acutely Restricted by Tethering)
"*" indicates required fields
OpenSPR and Alto webinar popup
Streamlining characterization of biomolecular binding
kinetics with Alto™ and OpenSPR®
"*" indicates required fields
Rising Investigators Webinar Popup
Rising Investigators in SPR
"*" indicates required fields
Detecting Emerging Viral Variants
"*" indicates required fields
OCMS Webinar Popup
Detecting Emerging Viral Variants
"*" indicates required fields
Laboratory Automation Webinar Popup
Laboratory Automation
"*" indicates required fields
Navigating the Post-Covid Research Landscape Popup
Navigating the Post-Covid Research Landscape
"*" indicates required fields
Covid-19 Diagnostics Using SPR Popup
Covid-19 Diagnostics Using SPR
"*" indicates required fields
Binding Techniques Webinar Popup
Binding Techniques
"*" indicates required fields
Enter the Nicosystem Webinar Popup
Enter the Nicosystem
"*" indicates required fields
Publish Faster With Binding Kinetics & Affinity Data
Over 600 researchers worldwide are using OpenSPR™ to get the data reviewers are looking for. Read our brochure to learn more!
"*" indicates required fields
Download Alto Brochure
The future of drug discovery is Alto.
Interested in learning more about how Alto can accelerate your drug discovery? Fill out the form below to download a product brochure.
